Object of the contractDiagnostic devices
Description: Contract notice: Diagnostic devices
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Restricted procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: The most economic tender
CPV code: 33124100, 33124100, 33124131, 33124130, 33124100, 33124131, 33124130, 33141625, 33696700, 33124110, 48180000, 48211000, 48200000, 85111800
CPV Description: Diagnostic devices.
Reagent strips.
Diagnostic supplies.
Diagnostic kits.
Urological reagents.
Diagnostic systems.
Medical software package.
Platform interconnectivity software package.
Networking, Internet and intranet software package.
Pathology services.
Framework for Point of Care Testing.
This tender is to establish a framework agreement for the supply of Point of Care Testing (POCT) equipment, consumables and related services. The framework will provide a comprehensive range of products to include handheld devices, bench-top devices, connected and non-connected devices, as well as consumables, such as test strips and cassettes, and other products that can be properly described as point of care or near-patient testing.
NUTS Code : UK
Blood-glucose monitoring systems are in vitro diagnostic medical devices used to measure the concentration of glucose in the blood.
Ketone Testing is used to diagnose Diabetic Ketoacidosis (DKA) in patients by quantifying the concentration of β-hydroxybutyrate in the blood.
Lot 1 (Blood Glucose and Ketone Testing) includes handheld meters, instruments, consumables and any other relevant product offering which can be properly described as providing blood glucose testing, as a minimum.
The Lot is divided into 2 product groups:
— Connected Blood Glucose and Ketone Meters and Consumables,
— Non-Connected Blood Glucose and Ketone Meters and Consumables.
Terms and Conditions / Activity Based Income (ABI)
The terms and conditions of this framework agreement and any resulting call-off contract is appended to the ITT. These terms include provisions requiring the payment by the supplier of an ABI management charge in consideration of the award of this framework agreement, the management and administration by HTE of the overall contract structure and associated documentation, as well as the requirement to submit regular management information to HTE.
Submission of Expressions of Interest and Procurement Information
This exercise will be conducted on the HTE Bravo portal. Candidates wishing to be considered must register expressions of interest as follows:
Register on the HTE portal at https://healthtrusteurope.bravosolution.co.uk. Login to the portal with username/password. Click the PQQs/ITTs Open to All Suppliers link. These are the PQQs/ITTs open to any registered supplier. Click on the relevant PQQ/ ITT to access the content. Click the Express Interest button at the top of the page. This will move the PQQ/ITT into your My PQQs/My ITTs page. You can access any attachments by clicking Buyer Attachments in the PQQ/ITT Details box. Follow the onscreen instructions to complete the PQQ/ITT. Submit your reply using the Submit Response button at the top of the page. If you require any further advice, contact the Bravo e-Tendering Help Desk at
[email protected]Sid4Gov
HTE utilises the sid4gov supplier information database. Candidates should register on sid4gov at https://sid4gov.cabinetoffice.gov.uk/organisation/register and submit their sid4gov company profile for publication on the database. Candidates already registered on sid4gov must ensure information is up to date. Where access to sid4gov is unavailable, please contact the sid4gov helpdesk at
[email protected]Please note that sid4gov does not prepopulate any fields of the PQQ on HTE's Bravo portal. Candidates must complete the Qualification and Technical Envelopes of the PQQ in Bravo in full.
HTE may request such information as may be requested pursuant to Regulation 58 of the Public Contracts Regulations 2015. Details are provided in the Selection Questionnaire.
HTE is a central purchasing body who is able to carry out this tender exercise by virtue of its appointment as an agent of UHCW. Notwithstanding HTE's relationship with UHCW, it is HTE conducting this tender exercise and will execute the resultant framework agreement with successful bidders.
The bodies to whom the use of this framework agreement will be open include all contracting authorities in the UK as defined in Regulation 2 of the Public Contracts Regulations 2015 as may be updated from time to time. In particular, the following entities in the UK (particularly those of a health and/or social care nature) are envisaged as framework agreement users:
(1) All National Health Service (NHS) bodies in England, including but not limited to:
(i) acute trusts (as listed at: http://www.nhs.uk/servicedirectories/pages/acutetrustlisting.aspx);
(ii) health and care trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx);
(iii) mental health trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/MentalHealthTrustListing.aspx);
(iv) clinical commissioning groups (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx);
(v) ambulance trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx)
(vi) area teams (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx);
(vii) special health authorities (http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx);
(viii) NHS England; and
(ix) clinical senates and strategic clinical networks.
(2) All NHS bodies in Wales, including but not limited to all:
(i) health boards;
(ii) NHS trusts;
(iii) the national delivery group;
(iv) community health councils; and
(v) NHS Wales shared services partnership (as listed at http://www.wales.nhs.uk/nhswalesaboutus/structure
(3) All NHS bodies in Northern Ireland (known as Health and Social Care), including but not limited to:
(i) health and social care trusts (as listed at: http://online.hscni.net/?s=trusts);
(ii) health agencies (as listed at: http://online.hscni.net/?s=health+agencies);
(iii) hospitals (as listed at: http://online.hscni.net/?s=hospitals); and
(iv) the Health and Social Care Board.
(4) Social enterprises undertaking some or all of the previous service provider functions of contracting authorities in relation to health and/or social care services (including charitable incorporated organisations, cooperatives, industrial and provident societies and community interest companies listed on the Companies House WebCheck service).
(5) Ministerial departments and non-ministerial departments of central government, non-departmental agencies and other public bodies, and public corporations (as listed at: https://www.gov.uk/government/organisations).
(6) Devolved governmental and parliamentary organisations within the UK, including but not limited to the Scottish Government, Scottish Parliament, and Scottish public bodies (as listed at: http://www.scotland.gov.uk/Topics/Government/public-bodies/about/Bodies), as well as the Welsh Government, Welsh Assembly and Welsh unitary authorities (as listed at: http://www.assembly.wales/en/abthome/role-of-assembly-how-it-works/Pages/governance-of-wales.aspx).
(7) All local authorities (as listed at: http://local.direct.gov.uk/LDGRedirect/Start.do?mode=1).
(8) The Ministry of Defence (as detailed at:https://www.gov.uk/government/organisations/ministry-of-defence).
This list includes each organisation's successors and assigns, any equivalent organisations and associated organisation created due to any organisational changes.
This agreement will be open to any bodies or organisations operating in the UK of a health, and/or social care nature or which have a similar procurement need, and/or any UK based central government authority listed at Annex I of Directive 2014/24/EU of the European Parliament and of the Council, in respect of any goods or services to any of the above listed organisations.
Internet address (URL): https://healthtrusteurope.bravosolution.co.uk
Directive: Classical Directive (2014/24/EU)